Anne M Suskind1, Chengshi Jin2, Louise C Walter3, Emily Finlayson4. 1. Department of Urology, University of California-San Francisco, San Francisco, California. Electronic address: Anne.Suskind@ucsf.edu. 2. Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California. 3. Division of Geriatrics, Department of Medicine, University of California-San Francisco, San Francisco, California; Division of Geriatrics, Veterans Affairs Medical Center, San Francisco, California. 4. Department of Surgery, University of California-San Francisco, San Francisco, California.
Abstract
PURPOSE: We sought to determine whether frailty affects the type of pelvic organ prolapse surgery performed and the odds of postoperative complications. MATERIALS AND METHODS: This is a retrospective cohort study of women who underwent obliterative and reconstructive surgery for pelvic organ prolapse in ACS (American College of Surgeons) NSQIP® (National Surgical Quality Improvement Program) from 2005 to 2013. We quantified frailty using NSQIP-FI (Frailty Index) and applied logistic regression models predicting the type of procedure (colpocleisis) and the odds of postoperative complications. RESULTS: We identified a total of 12,731 women treated with pelvic organ prolapse repair, of which 5.3% were colpocleisis procedures, from 2005 to 2013. Among women undergoing colpocleisis, the average age was 79.2 years and 28.5% had a NSQIP-FI of 0.18 or higher, indicating frailty. Women undergoing colpocleisis procedures had higher odds of being frail (NSQIP-FI 0.18 vs 0 OR 1.9, 95% CI 1.4-2.6) and were older (age 85+ vs less than 65 years OR 486.4, 95% CI 274.6-861.7). For all types of pelvic organ prolapse procedures, frailty increased the odds of complications (NSQIP-FI 0.18 vs 0 OR 2.8, 95% CI 1.8-3.0), after adjusting for age and type of pelvic organ prolapse procedure. CONCLUSIONS: For pelvic organ prolapse surgery, age rather than frailty is more strongly associated with the type of procedure performed. However, frailty is more strongly associated with postoperative complications than age. Furthermore, incorporating frailty into preoperative decision making is important to improve expectations and outcomes among older women considering pelvic organ prolapse surgery.
PURPOSE: We sought to determine whether frailty affects the type of pelvic organ prolapse surgery performed and the odds of postoperative complications. MATERIALS AND METHODS: This is a retrospective cohort study of women who underwent obliterative and reconstructive surgery for pelvic organ prolapse in ACS (American College of Surgeons) NSQIP® (National Surgical Quality Improvement Program) from 2005 to 2013. We quantified frailty using NSQIP-FI (Frailty Index) and applied logistic regression models predicting the type of procedure (colpocleisis) and the odds of postoperative complications. RESULTS: We identified a total of 12,731 women treated with pelvic organ prolapse repair, of which 5.3% were colpocleisis procedures, from 2005 to 2013. Among women undergoing colpocleisis, the average age was 79.2 years and 28.5% had a NSQIP-FI of 0.18 or higher, indicating frailty. Women undergoing colpocleisis procedures had higher odds of being frail (NSQIP-FI 0.18 vs 0 OR 1.9, 95% CI 1.4-2.6) and were older (age 85+ vs less than 65 years OR 486.4, 95% CI 274.6-861.7). For all types of pelvic organ prolapse procedures, frailty increased the odds of complications (NSQIP-FI 0.18 vs 0 OR 2.8, 95% CI 1.8-3.0), after adjusting for age and type of pelvic organ prolapse procedure. CONCLUSIONS: For pelvic organ prolapse surgery, age rather than frailty is more strongly associated with the type of procedure performed. However, frailty is more strongly associated with postoperative complications than age. Furthermore, incorporating frailty into preoperative decision making is important to improve expectations and outcomes among older women considering pelvic organ prolapse surgery.
Authors: Mira Shiloach; Stanley K Frencher; Janet E Steeger; Katherine S Rowell; Kristine Bartzokis; Majed G Tomeh; Karen E Richards; Clifford Y Ko; Bruce L Hall Journal: J Am Coll Surg Date: 2009-11-22 Impact factor: 6.113
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Anne M Suskind; Louise C Walter; Chengshi Jin; John Boscardin; Saunak Sen; Matthew R Cooperberg; Emily Finlayson Journal: BJU Int Date: 2016-01-17 Impact factor: 5.588
Authors: Elisabeth A Erekson; Terri R Fried; Deanna K Martin; Thomas J Rutherford; Kris Strohbehn; Julie P W Bynum Journal: Int Urogynecol J Date: 2014-12-17 Impact factor: 2.894
Authors: Tatiana Catanzarite; Aksharananda Rambachan; Margaret G Mueller; Matthew A Pilecki; John Y S Kim; Kimberly Kenton Journal: J Urol Date: 2014-03-15 Impact factor: 7.450
Authors: Maria J Arcila-Ruiz; Dean G Assimos; Benjamin M Brucker; Michael B Chancellor; Sasha C Druskin; J Curtis Nickel; Alan W Partin; Ellen Shapiro Journal: Rev Urol Date: 2017
Authors: Katherine A Amin; Una J Lee; Chengshi Jin; John Boscardin; Andrew R Medendorp; Jennifer T Anger; Anne M Suskind Journal: Urology Date: 2019-07-11 Impact factor: 2.649
Authors: T Clark Powell; Isuzu Meyer; Chee Paul Lin; Kelsey Lipking; Holly E Richter Journal: Female Pelvic Med Reconstr Surg Date: 2021-08-01 Impact factor: 2.091